微信小陈
微信小章
产品简介
购买须知
| 产品名称： | #595 S-595 |
|---|---|
| 商品货号： | TS136924 |
| Designations： | #595 S-595 |
| Depositors： | Otsuka Pharmaceuticals Co., Ltd., PM Arthur, Otsuka Pharmaceuticals Co., Ltd. |
| U.S. Patent： | |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Biosafety Level： | 1 |
| Vector Information： | Size (kb): 4.5560002326965330 Vector: #595 (plasmid) Promoters: Promoter for expression lambda PR Marker(s):ampR Construct size (kb): 4.556000232696533 Features: marker(s): ampR promoter for expression: lambda PR replicon: pMB1 repressor gene: cI857 restriction site: BamHI restriction site: ClaI terminator: lambda 4s coding sequence: IL-1, mature peptide |
| Applications： | contains sequence interleukin 1, beta |
| Comments： | A putative RBS can be cloned into the ClaI site using a double stranded oligonucleotide having a GC overhang at the 3 end. The vector allows testing of various oligonucleotide sequences as suitable ribosome binding sites (RBS) for expression of the gene in prokaryotic cells. The plasmid construct lacks a 5 leader sequence and RBS. The optimal RBS may vary from protein to protein. To facilitate testing other proteins, the insert coding sequence can be replaced by other foreign gene sequences, using ClaI and BamHI. The foreign gene must provide its own ATG initiation codon. Recommendation for verification: BamHI+ClaI, BglI, PstI. |
| Media： | ATCC® Medium 1315: LB Medium (ATCC medium 1065) with 100 mg/L ampicillin |
| Growth Conditions： | Temperature: 30.0°C |
| References： | Arthur PM, Duckworth BC. Gene regulation cassettes, expression vectors containing the same and microorganisms transformed with the same. US Patent 5,427,924 dated Jun 27 1995 |